Wilms' tumor 1 expression combined with genetic mutations for prognostic assessment in MDS.

Pan, Danqi; Zhao, Wenshu; Jiang, Qianli; Yin, Changxin; He, Han; Liao, Libin; Ye, Jieyu; Dai, Min

Pan, Danqi; Zhao, Wenshu; Jiang, Qianli; Yin, Changxin; He, Han; Liao, Libin; Ye, Jieyu; Dai, Min.

Afiliação

Pan D; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Zhao W; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Jiang Q; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Yin C; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
He H; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Liao L; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Ye J; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Dai M; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Leuk Lymphoma ; 64(4): 856-864, 2023 04.

Article em En | MEDLINE | ID: mdl-36905177

Assuntos

Neoplasias Renais; Síndromes Mielodisplásicas; Proteínas WT1; Tumor de Wilms; Humanos; Mutação; Síndromes Mielodisplásicas/diagnóstico; Síndromes Mielodisplásicas/genética; Prognóstico; Estudos Retrospectivos; Proteínas WT1/genética; Proteínas WT1/metabolismo

Palavras-chave

Myelodysplastic syndromes; Wilms' tumor 1; gene mutations; prognosis biomarker

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Tumor de Wilms / Proteínas WT1 / Neoplasias Renais Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google